Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)

Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Schimanski, Carl Christoph; Staib, Frank; Goehler, Thomas et al.

Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 143. H. 6. 2017 S. 1023-1034


Michel, C. S.; Teschner, D.; Wagner, E. M. et al.

Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation

ANNALS OF HEMATOLOGY. Bd. 96. H. 12. 2017 S. 2095-2101



Gribko, Alena; Hahlbrock, Angelina; Strieth, Sebastian et al.

Disease-relevant signalling-pathways in head and neck cancer: Taspase1's proteolytic activity fine-tunes TFIIA function

SCIENTIFIC REPORTS. Bd. 7. 2017


Castven, Darko; Becker, Diana; Wilhelm, Diana et al.

Dissection of genomic and transcriptomic profiles of patient-derived liver cancer cells enables therapeutic target identification

HEPATOLOGY. Bd. 66. 2017 S. 367A-368A


Geue, Kristina; Rieckhof, Sophia; Buttstaedt, Marianne et al.

Do cancer patients with high levels of distress benefit more than less distressed patients from outpatient art therapy?

EUROPEAN JOURNAL OF ONCOLOGY NURSING. Bd. 30. 2017 S. 1-7


Rahimi-Nedjat, R.; Sagheb, K.; Al-Nawas, B. et al.

Does the Inhibition of the Hedgehog-Signaling Pathway affect malignant Melanoma?: An in-vitro Study

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 31-31


Worns, Marcus-Alexander; Galle, Peter Robert; Zeuzem, Stefan et al.

Drug Treatment for Chronic Hepatitis C Infection and Cancer Risk

DEUTSCHES ARZTEBLATT INTERNATIONAL. Bd. 114. H. 35-36. 2017 S. 597-+


Diehn, Maximilian; Alizadeh, Ash A.; Adams, Hans-Peter et al.

Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA).

JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017